MRT (TSE:6034) Total Equity: 円4,569 Mil (As of Mar. 2026)


TSE:6034 MRT Inc TSE:6034
63 GF Score
Price 円635.00
GF Value 円632.15
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is MRT Total Equity?

MRT TSE:6034 +0.63% 63 Total Equity is 円4,569 Mil as of Mar. 2026. GuruFocus rates TSE:6034 with a GF Score™ of 63/100 and a GF Value™ of 円632.15 (Fairly Valued). The stock has 4 warning signs investors should review.

MRT's total equity for the quarter that ended in Mar. 2026 was 円4,569 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

MRT Total Equity Historical Data

* Premium members only.

The historical data trend for MRT's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MRT Total Equity Chart

MRT Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,293.28 4,484.78 4,716.64 4,627.60 4,646.59

MRT Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,404.82 4,497.70 4,529.01 4,646.59 4,568.72
TSE:6034
63GF Score
MRT Inc TSE:6034
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MRT Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

MRT's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=6477.632-1831.046
=4,647

MRT's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=6203.141-1634.426
=4,569

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of 円4,569 Mil mean?
MRT (TSE:6034) has a Total Equity of 円4,569 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for MRT and its competitors.
Is MRT's Total Equity too high?
MRT's current Total Equity is 円4,569 Mil. Overall, MRT has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MRT's Total Equity compare to HCA and THC?
MRT's Total Equity of 円4,569 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Healthcare Providers & Services company?
A good Total Equity depends on the Healthcare Providers & Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for MRT and its competitors. MRT's current Total Equity is 円4,569 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRT stock overvalued right now?
Based on GuruFocus' analysis, MRT (TSE:6034) is currently considered Fairly Valued. The stock's GF Value™ is 円632.15, compared to a current price of 円635.00 — trading 0.5% above its estimated fair value. The current Total Equity is 円4,569 Mil. MRT's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For MRT (TSE:6034), the current Total Equity is 円4,569 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MRT (TSE:6034) Overvalued in 2026?

Based on GuruFocus' analysis, MRT stock appears to be overvalued. The current stock price of 円635.00 is trading 0.5% above its estimated GF Value™ of 円632.15. GuruFocus considers MRT to be Fairly Valued.

Key valuation signals for TSE:6034:

  • Total Equity: 円4,569 Mil
  • GF Value™: 円632.15 vs. price of 円635.00 (0.5% above fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the TSE:6034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MRT Business Description

Address 1-18-2 Jinnan, 3rd Floor, Frame Jinnanzaka, Shibuya-ku, Tokyo, JPN, 150-0041
MRT Inc engages in the business of medical personnel placement services through the Internet. It provides part-time and full-time physician referral services through the physician referral site, as well as part-time job referral, job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers, and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.
63GF Score

Get the complete analysis for TSE:6034

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円635.00
Price
円632.15
GF Value